Investment Analysts’ Updated EPS Estimates for August, 11th (HWCC, ICHR, INVVY, IRET, ISTR, JNCE, KAR, KDMN, KELYA, KEYW)

Investment Analysts’ updated eps estimates for Friday, August 11th:

Houston Wire & Cable (NASDAQ:HWCC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “With more than three decades of experience in the electrical industry, HOUSTON WIRE & CABLE COMPANY is one of the largest distributors of specialty wire and cable and related services in the U.S. electrical distribution market. Headquartered in Houston, HWCC has sales and distribution facilities in Atlanta, Baton Rouge, Charlotte, Chicago, Denver, Houston, Los Angeles, Philadelphia, San Francisco, Seattle and Tampa. Standard stock items available for immediate delivery include continuous and interlocked armor, instrumentation, medium voltage, high temperature, portable cord, power cables and private branded products, including LifeGuard, a low-smoke, zero-halogen cable. HWCC’s comprehensive value-added services include same-day shipping, knowledgeable sales staff, inventory management programs, just-in-time delivery, logistics support, customized internet-based ordering capabilities and round-the-clock, throughout-the-year service. “

Ichor Holdings (NASDAQ:ICHR) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $21.00 target price on the stock. According to Zacks, “Ichor Holdings, Ltd. is engaged in the design, engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment. Ichor Holdings, Ltd. is based in Fremont, United States. “

Indivior Plc Spon (NASDAQ:INVVY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States. “

Investors Real Estate Trust (NYSE:IRET) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Investors Real Estate Trust is a real estate investment trust operating in the Midwest. “

Investar Holding Corp (NASDAQ:ISTR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $25.00 target price on the stock. According to Zacks, “Investar Holding Corporation is a bank holding company for Investar Bank. It offers a range of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses and professional concerns, as well as loans to individuals. The company accepts various deposit products, including savings, checking, money market, and NOW accounts, as well as various certificates of deposit and individual retirement accounts. It also provides cash management products and services, such as remote deposit capture, electronic statements, positive pay, ACH origination and wire transfer, investment sweep accounts, and business Internet banking, as well as debit cards and mobile banking services. Investar Holding Corporation is headquartered in Baton Rouge, Louisiana. “

Jounce Therapeutics (NASDAQ:JNCE) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $13.00 target price on the stock. According to Zacks, “Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company’s lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States. “

KAR Auction Services (NYSE:KAR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “KAR Auction Services, Inc., through its subsidiaries, operates as a used vehicle and salvage auto auction company in North America. The company operates in three segments: ADESA, IAAI, and AFC. The ADESA segment provides whole car auctions and related services to commercial fleet operators, financial institutions, rental car companies, used vehicle dealers, vehicle manufacturers and their captive finance companies, and franchised and independent used vehicle dealers. This segment also provides value-added ancillary services, such as inspections, storage, transportation, reconditioning and titling, and other administrative services. The IAAI segment offers salvage vehicle auctions and related services. The AFC segment offers short-term and inventory-secured financing, known as floorplan financing, to independent used vehicle dealers. KAR Auction Services, Inc. is headquartered in Carmel, Indiana. “

Kadmon Holdings (NASDAQ:KDMN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Kadmon Holdings, Inc. is a biopharmaceutical company. It engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need. The company is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases. Kadmon Holdings, Inc. is headquartered in New York. “

Kelly Services (NASDAQ:KELYA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $24.00 price target on the stock. According to Zacks, “KELLY SERVICES, INC. provides temporary office clerical, marketing, professional, technical, light industrial, home care services, management services and other business services to a diversified group of customers through offices located in major cities of the United States, Australia, Canada, Denmark, France, Ireland, Italy, Luxembourg, Mexico, the Netherlands, New Zealand, Norway, Russia, Spain, Switzerland and United Kingdom. Kelly Temporary Services provides office clerical, marketing, professional, technical, semi-skilled light industrial and management services. “

The KEYW Holding Corporation (NASDAQ:KEYW) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “KEYW Corporation with its subsidiaries is engaged in providing mission-critical cyber security and cyber superiority solutions to defense, intelligence and national security agencies. Its solutions, services and products support the collection, processing, analysis, and use of intelligence data and information in the domain of cyberspace. The Company provides a full range of engineering services as well as fully integrated platforms that support the entire intelligence process. Its platform includes products that it manufactures, as well as hardware and software that the Company integrates using its engineering services. Its current customers include the National Security Agency (NSA), other intelligence agencies, the Department of Defense (including major agencies and branches within the Department of Defense) and other federal defense and law enforcement agencies. KEYW Corporation is headquartered in Hanover, Maryland. “

Kindred Healthcare (NYSE:KND) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

Ladder Capital Corp (NASDAQ:LADR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ladder Capital Corp is a commercial real estate finance company. The Company operates in three segments: Loans, Securities and Real Estate. It focused on midmarket senior secured commercial real estate first mortgage loans, investment grade-rated securities secured by first mortgage loans on commercial real estate and investing in net leased and other commercial real estate. The company also provides services of the commercial real estate industry which includes origination, credit, underwriting, structuring, capital markets and asset management. Ladder Capital Corp is headquartered in New York City. “